Peter F. Nixon

Peter F. Nixon

Auto-generated profile, based on publicly available information

Peter F. Nixon

Department of Biochemistry, University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

64Years (1963-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1998 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Gerhard ("Gary") SchenkGerhard ("Gary") Schenk
Gerhard ("Gary") Schenk
RDRonald G. Duggleby
Ronald G. Duggleby
PNPeter F. Nixon
Peter F. Nixon

1 November 1967 in Analytical Biochemistry
Verified
Journal Article
Closed access
BHB.L. Hillcoat
B.L. Hillcoat
PNP.F. Nixon
P.F. Nixon
RBR.L. Blakley
R.L. Blakley

1 June 1971 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MLM. Levitt
M. Levitt
PNP. F. Nixon
P. F. Nixon
JPJ. H. Pincus
J. H. Pincus
JBJ. R. Bertino
J. R. Bertino
Serum disappearance curves in dogs after the intravenous injection of radioactive methotrexate, 5-methyltetrahydrofolate, 5-formyltetrahydrofolate, and folic acid followed first-order kinetics with half-disappearance times ranging from 1.3 to 9 hr respectively. Equilibration of spinal fluid tritium levels with those in serum was rapid (3.0 hr) for both of the reduced folates but was not observed at any time after folic acid and methotrexate. The only radioactive folate identified in the spinal fluid after intravenous injection of either 5-formyltetrahydrofolate or folic acid, as well as 5-methyltetrahydrofolate was 5-methyltetrahydrofolate. These findings indicated that 5-methyltetrahydrofolate was taken up preferentially into the spinal fluid and that the other folate congeners were converted to this compound before uptake. Diphenylhydantoin administration did not alter the uptake of 5-methyltetrahydrofolate into the spinal fluid but was associated with reduced renal excretion of this compound.

27 January 1972 in New England Journal of Medicine
Verified
Journal Article
Closed access
PNPeter F. Nixon
Peter F. Nixon
JBJoseph R. Bertino
Joseph R. Bertino
Reversal of the effects of antifolates requires effective expansion of the body pool of reduced folate coenzymes. In the past, this has required parenteral use of 5-formyltetrahydrofolate. By use of Radio-labeled 5-formyltetrahydrofolate, we showed that its oral administration also expands the body reduced folate pool. After oral administration of 5-formyl-14C-tetrahydrofolate-3H to fasting subjects, the labels appeared in the serum, peaking at 60 minutes. Chromatographic analysis showed that the labeled serum folate was principally the naturally occurring 5-methyltetrahydrofolate-3H. Close to 90 per cent of orally administered 5-formyltetrahydrofolate appeared to be absorbed. The most constant labeled urinary folate was found to be 10-formyltetrahydrofolate or 5, 10-methenyltetrahydrofolate. Renal excretion of labeled 5-formyltetrahydrofolate occurred at undetectable serum levels whereas renal excretion of labeled 5-methyltetrahydrofolate was proportional to its serum concentration.

1 August 1984 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
PNPeter F. Nixon
Peter F. Nixon
MKM. Jan Kaczmarek
M. Jan Kaczmarek
JTJill Tate
Jill Tate
RKRay A. Kerr
Ray A. Kerr
JPJohn Price
John Price

1 September 2002 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MJMartina Jones
Martina Jones
PNPeter F. Nixon
Peter F. Nixon
The dietary supply of folates and their measurement are both affected, potentially, by the instability of some folates. Labile folates appear to be stabilized by binding to folate-binding protein (FBP); this paper reports measurements of that stabilization. The degradation rates of the very labile tetrahydrofolate (H4folate) and moderately labile 5-methyltetrahydrofolate (5-CH3H4folate) were measured with the compounds free or bound to either soluble or immobilized bovine milk FBP. Complexation increased stability from 2- to > 1000-fold, depending on buffer and temperature conditions. H4folate at 4°C and pH 6.7 appeared to be quite stable for > 100 d when bound to soluble FBP but had a half-life of < 1 h when free. Stabilization of milk folates may be a role of FBP and would improve the bioavailability of milk folate to newborns and other consumers.